1. Home
  2. BOLD vs ARKR Comparison

BOLD vs ARKR Comparison

Compare BOLD & ARKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • ARKR
  • Stock Information
  • Founded
  • BOLD 2018
  • ARKR 1983
  • Country
  • BOLD United States
  • ARKR United States
  • Employees
  • BOLD N/A
  • ARKR N/A
  • Industry
  • BOLD
  • ARKR Restaurants
  • Sector
  • BOLD
  • ARKR Consumer Discretionary
  • Exchange
  • BOLD Nasdaq
  • ARKR Nasdaq
  • Market Cap
  • BOLD 24.4M
  • ARKR 25.3M
  • IPO Year
  • BOLD 2024
  • ARKR N/A
  • Fundamental
  • Price
  • BOLD $1.17
  • ARKR $7.08
  • Analyst Decision
  • BOLD Buy
  • ARKR
  • Analyst Count
  • BOLD 4
  • ARKR 0
  • Target Price
  • BOLD $4.00
  • ARKR N/A
  • AVG Volume (30 Days)
  • BOLD 80.0K
  • ARKR 19.8K
  • Earning Date
  • BOLD 08-05-2025
  • ARKR 08-11-2025
  • Dividend Yield
  • BOLD N/A
  • ARKR N/A
  • EPS Growth
  • BOLD N/A
  • ARKR N/A
  • EPS
  • BOLD N/A
  • ARKR N/A
  • Revenue
  • BOLD N/A
  • ARKR $171,834,000.00
  • Revenue This Year
  • BOLD N/A
  • ARKR N/A
  • Revenue Next Year
  • BOLD N/A
  • ARKR N/A
  • P/E Ratio
  • BOLD N/A
  • ARKR N/A
  • Revenue Growth
  • BOLD N/A
  • ARKR N/A
  • 52 Week Low
  • BOLD $1.00
  • ARKR $6.38
  • 52 Week High
  • BOLD $4.72
  • ARKR $17.76
  • Technical
  • Relative Strength Index (RSI)
  • BOLD 51.81
  • ARKR 35.23
  • Support Level
  • BOLD $1.09
  • ARKR $6.97
  • Resistance Level
  • BOLD $1.19
  • ARKR $7.40
  • Average True Range (ATR)
  • BOLD 0.05
  • ARKR 0.39
  • MACD
  • BOLD -0.00
  • ARKR 0.03
  • Stochastic Oscillator
  • BOLD 82.76
  • ARKR 52.24

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About ARKR Ark Restaurants Corp.

Ark Restaurants Corp owns and operates around 17 restaurants and bars, 16 fast food concepts, and catering operations in the USA. The Las Vegas operations include New York Hotel & Casino Resort, hotel room service operations, banquet facilities, employee dining room, food court concepts, and a restaurant within the Planet Hollywood Resort and Casino. It operates a restaurant and a bar in the Resorts Atlantic City Hotel and Casino and a restaurant in the Tropicana Hotel and Casino. The Florida operations include The Rustic Inn in Dania Beach, Shuckers in Jensen Beach, JB's on the Beach in Deerfield Beach, The Blue Moon Fish Company in Fort Lauderdale, and fast food facilities in Tampa and Hollywood. In Alabama, it operates Original Oyster Houses in Gulf Shores and Spanish Fort.

Share on Social Networks: